Lidé

Jméno Řezáčová Pavlína
Pozice Vedoucí vědecké skupiny
Dr. Pavlína Řezáčová

Pavlína Řezáčová, Ph.D.

Head of the Senior Research Group


Structural Biology
Institute of Organic Chemistry and Biochemistry ASCR, v.v.i.
Flemingovo nám. 2, CZ-166 10 Prague 6, Czech Republic

Phone: (+420) 220 183 135 / 220 183 210 / 220 183 212

 

 
Education
1997-2004 Ph.D. in Molecular biology, genetics and virology, Faculty of Sciences, Charles University, Prague.
1992-1997 M.Sc. (Mgr.) in Molecular biology, genetics and virology, Faculty of Sciences, Charles University, Prague.
 
Experience
2005-2007 Postdoctoral fellow at UT Southwestern Medical Center, Department of Biochemistry, Dallas, TX, U.S.A, with Prof. Z.Otwinowski.
2000 Short term EMBO fellowship at Department of Structural Immunology, Paris, France, with Prof. G.A.Bentley.
 
Appointments
since 2007 Head of the Structural biology research group, Institute of Organic Chemistry and Biochemistry v.v.i., Academy of Sciences of the Czech Republic, Prague.
since 2007 Head of the Structural biology research group, Institute of Molecular Genetics v.v.i., Academy of Sciences of the Czech Republic, Prague.
1997-2005 Ph.D. student at Institute of Molecular Genetics AS CR, Prague, Department of Recombinant Expression and Structural Biology.
1997-2005 M.Sc. student at Institute of Molecular Genetics AS CR, Prague, Department of Gene Manipulation.
 
Teaching
since 2003 Determination of 3-D structures of macromolecules course, Faculty of Sciences, Charles University, Prague.
2001-2005 Organizing and teaching at practical courses: Crystallization course CC2001, CC2002 and CC2003, CC2005 University and Academic Center Nové Hrady, Czech Republic.
2004, 2006, 2008 Organizing and teaching at FEBS advanced courses: Advanced methods in protein crystallization, University and Academic Center Nové Hrady, Czech Republic.
2005 Teaching at International School on Biological Crystallization, University of Granada, Spain.
 
Research interest
Protein crystallization techniques, protein crystallography, HIV protease, structure-assisted drug design, prokaryotic transcriptional repressors, antibody fragments.
 
Papers